Ljunggren HG - Search Results

1

Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis.

Wang HB, Shi FD, Li H, Chambers BJ, Link H, Ljunggren HG. Wang HB, et al. Among authors: ljunggren hg. J Immunol. 2001 May 15;166(10):6430-6. doi: 10.4049/jimmunol.166.10.6430. J Immunol. 2001. PMID: 11342669

2

Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.

Ljunggren HG, Sturmhöfel K, Wolpert E, Hämmerling GJ, Kärre K. Ljunggren HG, et al. J Immunol. 1990 Jul 1;145(1):380-6. J Immunol. 1990. PMID: 2113557

3

Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant.

Ohlén C, Bastin J, Ljunggren HG, Foster L, Wolpert E, Klein G, Townsend AR, Kärre K. Ohlén C, et al. Among authors: ljunggren hg. J Immunol. 1990 Jul 1;145(1):52-8. J Immunol. 1990. PMID: 2358681

4

Studies of sublines selected for loss of HLA expression from an EBV-transformed lymphoblastoid cell line. Changes in sensitivity to cytotoxic T cells activated by allostimulation and natural killer cells activated by IFN or IL-2.

Ohlén C, Bejarano MT, Grönberg A, Torsteinsdottir S, Franksson L, Ljunggren HG, Klein E, Klein G, Kärre K. Ohlén C, et al. Among authors: ljunggren hg. J Immunol. 1989 May 1;142(9):3336-41. J Immunol. 1989. PMID: 2468716

5

Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.

Ljunggren HG, Ohlén C, Höglund P, Yamasaki T, Klein G, Kärre K. Ljunggren HG, et al. J Immunol. 1988 Jan 15;140(2):671-8. J Immunol. 1988. PMID: 3335786

6

Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo.

Liu T, Zhou X, Orvell C, Lederer E, Ljunggren HG, Jondal M. Liu T, et al. Among authors: ljunggren hg. J Immunol. 1995 Apr 1;154(7):3147-55. J Immunol. 1995. PMID: 7897204

7

Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells.

Salcedo M, Momburg F, Hämmerling GJ, Ljunggren HG. Salcedo M, et al. Among authors: ljunggren hg. J Immunol. 1994 Feb 15;152(4):1702-8. J Immunol. 1994. PMID: 8120379

8

TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity.

Sandberg JK, Chambers BJ, Van Kaer L, Kärre K, Ljunggren HG. Sandberg JK, et al. Among authors: ljunggren hg. Eur J Immunol. 1996 Feb;26(2):288-93. doi: 10.1002/eji.1830260203. Eur J Immunol. 1996. PMID: 8617293

9

Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1).

Chambers BJ, Salcedo M, Ljunggren HG. Chambers BJ, et al. Among authors: ljunggren hg. Immunity. 1996 Oct;5(4):311-7. doi: 10.1016/s1074-7613(00)80257-5. Immunity. 1996. PMID: 8885864 Free article.

10

Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells.

Norbury CC, Chambers BJ, Prescott AR, Ljunggren HG, Watts C. Norbury CC, et al. Among authors: ljunggren hg. Eur J Immunol. 1997 Jan;27(1):280-8. doi: 10.1002/eji.1830270141. Eur J Immunol. 1997. PMID: 9022030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

364 results

Search Page

Filters